Clinical Oncology
Volume 22, Issue 2 , Pages 97-106 , March 2010

Attitudes of Canadian Radiation Oncologists towards Post-lumpectomy Radiotherapy for Elderly Women with Stage I Hormone-responsive Breast Cancer

  • E. Warner

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
    • ,
  • E. Chow

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
    • ,
  • A. Fairchild

      Affiliations

    • Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
    • ,
  • E. Franssen

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
    • Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
    • Faculty of Medicine, University of Toronto, Canada
    • ,
  • L. Paszat

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
    • ,
  • E. Szumacher

      Affiliations

    • Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationAuthor for correspondence: E. Szumacher, Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, 2075 Bayview Avenue, Toronto, ON, M4N3M5, Canada. Tel: +416-480-4834; Fax: +416-480-6002.

Received 13 March 2009 ,Revised 9 September 2009 ,Accepted 1 October 2009.

References 

  1. Morrow M, Harris JR. Local management of invasive breast cancer. In:  Harris JR,  Lippman ME,  Morrow M,  Osborne CK editor. Diseases of the breast. 2nd edn. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 515–560
  2. Fyles AW, McCready DR, Manchul LA, et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351:963–970
  3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  4. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol. 2002;20:4141–4149
  5. Lee SH, Chung MA, Chelmow D, et al. Avoidance of adjuvant radiotherapy in selected patients with invasive breast cancer. Ann Surg Oncol. 2004;11:316–321
  6. Potter R, Gnant M, Kwasny W, et al. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer. Int J Radiat Oncol Biol Phys. 2007;68:334–340
  7. Buchholz TA, Tucker SL, Erwin J, et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol. 2001;19:2240–2246
  8. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst. 2000;92:550–556
  9. Bartelink H, Horiot J-C, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 2001;345:1378–1387
  10. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–977
  11. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet. 2005;366:2087–2106
  12. Hughes KS. Why do we believe that breast cancer in the elderly is the same as breast cancer in young women?. Drugs Aging. 2008;25:47–48
  13. Brennan M, Hoek J. The behavior of respondents, non-respondents, and refusers across mail surveys. Public Opin Q. 1992;56:330–335
  14. Kaplowitz M, Hadlock T, Levine R. A comparison of web and mail survey response rates. Public Opin Q. 2004;68:94–101
  15. Pradhan K. The internet in Nepal: a survey report. Int Inform Libr Rev. 1999;31:41–47
  16. Sheehan K. E-mail survey response rates: a review. J Compu-Mediat Commun. 2001;6(2):
  17. Ende J, Kazis L, Ash A, Moskowitz MA. Measuring patients' desire for autonomy: decision-making and information-seeking preferences among medical patients. J Gen Intern Med. 1989;4:23–30
  18. Beisecker AE, Beisecker TD. Patient information-seeking behaviors when communicating with doctors. Med Care. 1990;28:19–28
  19. Deber RA, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making?. Arch Intern Med. 1996;156:1414–1420
  20. Rothenbacher D, Lutz MP, Porzsolt F. Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about it. Eur J Cancer. 1997;33:1184–1189
  21. Bruera E, Sweeney C, Kalder K. Patient preferences versus physician perceptions of treatment decisions in cancer care. J Clin Oncol. 2001;19:2884–2885
  22. O'Conner AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(2):CD001431
  23. Brody DS, Miller SM, Lerman CE, et al. Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med. 1989;4:506–511
  24. Kaplan SH, Greenfield S, Ware J. Assessing the effects of physician–patient interactions on the outcomes of chronic disease. Med Care. 1989;27:S110–S127
  25. Greenfield S, Kaplan SH, Ware J. Expanding patient involvement in care: effects on patient outcomes. Ann Intern Med. 1985;102:520–528
  26. Levine MN, Gafni A, Markham B, et al. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med. 1992;117:53–58
  27. Whelan TJ, Levine MN, Gafni A, et al. Breast irradiation post-lumpectomy: development and evaluation of a decision instrument. J Clin Oncol. 1995;13:847–853
  28. Sepucha KR, Belkora JK, Tripathy D, et al. Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision making in breast cancer. J Clin Oncol. 2000;18:1230–1238
  29. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19:980–991
  30. Molennar S, Sprangers MA, Rutgers EJ, et al. Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. J Clin Oncol. 2001;19:1676–1687
  31. Whelan TJ, Sawka C, Levine M, et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst. 2003;95:581–587
  32. Whelan T, Levine M, Willan A, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004;292(4):435–444

PII: S0936-6555(09)00328-8

doi: 10.1016/j.clon.2009.10.001

Clinical Oncology
Volume 22, Issue 2 , Pages 97-106 , March 2010

Article Tools